TREATMENT OF FULMINANT VIRAL HEPATITIS B WITH ACUTE HEPATIC ENCEPHALOPATHY WITH INTRAVENOUS IMMUNOGLOBULIN: PRESENTATION OF A CLINICAL CASE
Article PDF

Keywords

viral hepatitis, acute liver failure, intravenous immunoglobulin

Abstract views: 121
PDF Downloads: 123

How to Cite

Maltsev, D., & Muzyca, D. (2017). TREATMENT OF FULMINANT VIRAL HEPATITIS B WITH ACUTE HEPATIC ENCEPHALOPATHY WITH INTRAVENOUS IMMUNOGLOBULIN: PRESENTATION OF A CLINICAL CASE. Medical Science of Ukraine (MSU), 13(1-2), 122-126. https://doi.org/10.32345/2664-4738.1-2.2017.17

Abstract

At hepatology intravenous immunoglobulin was tested in several areas, but the evidence base of effectiveness is different at each nosology and often insufficient for routine use of the drug. However, immunoglobulin therapy may be useful for hepatologist in the management of severe, unusual clinical cases in the framework of a personalized treatment, in connection with which specialist should be well informed about the current experience of using immunotherapy for various hepatological indications.

This article describes clinical case of fulminant viral hepatitis B with acute liver failure and encephalopathy in which managed to save the life of the patient only after the addition to the standard treatment regimen intravenous immunoglobulin.

https://doi.org/10.32345/2664-4738.1-2.2017.17
Article PDF

References

Bejaoui M., Gharbi A., Bouguerra A. et al. Successful treatment of chronic active hepatitis with high-dose intravenous immunoglobulins in agammaglobulinemia // Arch. Pediatr. 1994. Vol. 1, No. 2. P. 158-161.

Belbezier A., Deroux A., Sarrot-Reynauld F. et al. Myasthenia gravis associated with acute hepatitis E infection in immunocompetent woman // Emerg. Infect. Dis. 2014. Vol. 20, No. 5. P. 908-910.

Cao Y.H., Zhang G.Y., Zhang G.C. Successful treatment with high-dose intravenous immunoglobulin for parvovirus b19 infection associated with acute fulminant hepatitis in a chinese child // Clin. Pediatr. (Phila). 2009. Vol. 48, No. 6. P. 674-676.

Galal N.M. Pattern of intravenous immunoglobulins (IVIG) use in a pediatric intensive care facility in a resource limited setting // Afr. Health Sci. 2013. Vol. 13, No. 2. P. 261-265.

Higuchi M.A., Fukae J., Tsugawa J. et al. Dysgeusia in a Patient with Guillain-Barré Syndrome Associated with Acute Hepatitis E: A Case Report and Literature Review // Intern. Med. 2015. Vol. 54, No. 12. P. 1543-1546.

Hirschi S., Biondini D., Ohana M. et al. Herpes simplex virus 2 hepatitis in a lung transplant recipient: a diagnostic challenge // Transpl. Infect. Dis. 2015. Vol. 17, No. 6. P. 904-908.

Hulstaert E., Verhelst X., Geerts A., Van Vlierberghe H. Intramuscular hepatitis B immunoglobulins for reinfection control after liver transplantation: a cost-saving alternative // J. Comp. Eff. Res. 2015. Vol. 8. P. 1-7.

Jimenez-Rivera C., Gupta A., Feberova J. et al. Successful treatment of neonatal hemochromatosis as gestational alloimmune liver disease with intravenous immunoglobulin // J. Neonatal. Perinatal. Med. 2014. Vol. 7, No. 4. P. 301-304.

Joanna G., Slawomir Z., Barbara R., Barbara R. Does the proper intravenous immunoglobulin substitution in primary immunodeficiency protect against HBV infections?: a description of a case series // Med. Microbiol. Immunol. 2008. Vol. 197, No. 3. P. 325-328.

Kerensky T., Hasan A., Schain D. et al. Histopathologic resolution of adult liver transplantation adenovirus hepatitis with cidofovir and intravenous immunoglobulin: a case report // Transplant. Proc. 2013. Vol. 45, 1. P. 293-296.

Lee S.W., Kim K.C., Oh D.H. et al. A case of polymyositis with dilated cardiomyopathy associated with interferon alpha treatment for hepatitis B // J. Korean. Med. Sci. 2002. Vol. 17, No. 1. P. 141-143.

Li A.M., Nelson E.A., Hon E.K. et al. Hepatic failure in a child with anti-epileptic hypersensitivity syndrome // J. Paediatr. Child. Health. 2005. Vol. 41, No. 4. P. 218-220.

Marsalli G., Nastasio S., Sciveres M. et al. Efficacy of intravenous immunoglobulin therapy in giant cell hepatitis with autoimmune hemolytic anemia: A multicenter study // Clin. Res. Hepatol. Gastroenterol. 2016. Vol. 40, No. 1. P. 83-89.

Pérard L., Costedoat-Chalumeau N., Limal N. et al. Hemophagocytic syndrome in a pregnant patient with systemic lupus erythematosus, complicated with preeclampsia and cerebral hemorrhage // Ann. Hematol. 2007. Vol. 86, No. 7. P. 541-544.

Polat A., Akca H., Dagdeviren E. Severe thrombocytopenia after hepatitis B vaccine in an infant from Turkey // Vaccine. 2008. Vol. 26, No. 51. P. 6495-6496.

Pourrat O., Ducroz B., Magnin G. Intravenous immunoglobulins in postpartum, persistently severe HELLP syndrome: a safe alternative to plasma exchange // Am. J. Obstet. Gynecol. 1992. Vol. 166, No. 2. P. 766.

Santos-García D., Arias-Rivas S., Dapena D, Arias M. Past hepatitis B virus infection and demyelinating multiphasic disease: casual or causal relationship? // Neurologia. 2007. Vol. 22, No. 8. P. 542-546.

Smíšková D., Blechová Z., Polanecká L. et al. Immune thrombocytopenia as a complication of acute infectious diseases - case reports // Klin. Mikrobiol. Infekc. Lek. 2013. Vol. 19, No. 1. P. 15-18.

Urbani L., Mazzoni A., De Simone P. et al. Treatment of antibody-mediated rejection with high-dose immunoglobulins in ABO-incompatible livertransplant recipient // Transpl. Int. 2007. Vol. 20, No. 5. P. 467-470.

Yi N.J., Lee K.W., Kong S.Y. et al. Outcome of various treatments for posttransplant hepatitis B virus recurrence // World J. Surg. 2013. Vol. 37, No. 4. P. 812-819.

Zhang L., Ko S., Lv J. et al. Perinatal hepatitis B prevention program in Shandong Province, China. Evaluation and progress. Hum. Vaccin. // Immunother. 2014. Vol. 10, No. 9. P. 2755-2760.

Zubkova N.V., Anastasiev V.V, Moiseeva M.A., Zubov S.V. Neutralization of hepatitis B virus surface antigen with immunoglobulin preparations // Zh. Mikrobiol. Epidemiol. Immunobiol. 2006. Vol. 2. P. 50-53.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.